This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Here's Why You Should Add eHealth (EHTH) to Your Portfolio
by Zacks Equity Research
Solid performance of the Medicare business makes eHealth (EHTH) well poised for growth.
Why eHealth (EHTH) Stock Might be a Great Pick
by Zacks Equity Research
eHealth (EHTH) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.
Zacks Industry Outlook Highlights: eHealth, Brown & Brown, Arthur J. Gallagher and Marsh & McLennan Companies
by Zacks Equity Research
Zacks Industry Outlook Highlights: eHealth, Brown & Brown, Arthur J. Gallagher and Marsh & McLennan Companies
Bright Near-Term Prospects for Insurance Brokerage Industry
by Tanuka De
Insurance - Brokerage Industry is poised for growth given growing demand for insurance even amid the pandemic.
What's in Store for Arthur J. Gallagher (AJG) in Q2 Earnings?
by Zacks Equity Research
Arthur J. Gallagher's (AJG) Q2 results are likely to reflect new business production, strategic buyouts, and organic revenue growth.
EHealth (EHTH) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
eHealth (EHTH) delivered earnings and revenue surprises of 138.89% and 6.51%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?
eHealth (EHTH) Gears Up for Q2 Earnings: What's in Store?
by Zacks Equity Research
eHealth's (EHTH) Q2 results are likely to reflect solid performance at Medicare and individual and family plan business.
Earnings Preview: eHealth (EHTH) Q2 Earnings Expected to Decline
by Zacks Equity Research
EHealth (EHTH) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Arthur J. Gallagher Boosts Portfolio With Cunnington Buyout
by Zacks Equity Research
Arthur J. Gallagher & Co. (AJG) buys Idaho-based Cunnington & Associates to expand its presence and boost cross-selling opportunities.
eHealth (EHTH) Moves to Strong Buy: Rationale Behind the Upgrade
by Zacks Equity Research
eHealth (EHTH) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
Arthur J. Gallagher Consolidates Employee Benefit Solutions
by Zacks Equity Research
Arthur J. Gallagher & Co. (AJG) buyout of Barrett, Liner & Buss expands its presence in northern Florida and boosts employee benefit solutions.
Here's Why You Should Stay Away from Aon (AON) Right Now
by Zacks Equity Research
Weak balance sheet and unfavorable forex fluctuations make Aon (AON) an unattractive bet.
Arthur J. Gallagher (AJG) Gains 11% in a Year: Here's Why
by Zacks Equity Research
Arthur J. Gallagher (AJG) stock rallies so far this year due to strong segmental performance.
Here's Why You Should Stay Away From Marsh & McLennan (MMC)
by Zacks Equity Research
Bleak 2020 guidance and flared-up expenses make Marsh & McLennan (MMC) an unattractive bet.
Is eHealth (EHTH) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
Willis Towers, The Hartford Partner for Captive Solution
by Zacks Equity Research
Willis Towers (WLTW) unveils a group captive solution for upper middle-market companies.
Arthur J. Gallagher (AJG) Boosts Portfolio With CRES Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) acquired CRES Insurance Services to consolidate its capabilities.
Arthur J. Gallagher (AJG) Expands in Brisbane With Buyout
by Zacks Equity Research
Arthur J. Gallagher (AJG) expand sits presence and capabilities in Brisbane with CA Insurance Brokers buyout.
Marsh & McLennan's Arm Buys Stake in Corridor Platforms
by Zacks Equity Research
Marsh & McLennan's (MMC) arm purchases a minority interest in Corridor Platforms for fast end-to-end credit decisioning.
Is eHealth (EHTH) Stock Outpacing Its Finance Peers This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
eHealth Gains 19% YTD: Can the Stock Retain the Momentum?
by Zacks Equity Research
Solid performance of the Medicare business helps eHealth (EHTH) continues the bull run.
Has eHealth (EHTH) Outpaced Other Finance Stocks This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?
Brown & Brown (BRO) Rides on Organic Growth, Expenses Rise
by Zacks Equity Research
Brown & Brown (BRO) is well poised for growth on the back of strategic mergers and acquisitions and robust capital position slightly offset by higher expenses.
Brown & Brown (BRO) Q1 Earnings Top Estimates, Revenues Up Y/Y
by Zacks Equity Research
Brown & Brown's (BRO) first-quarter 2020 results reflect organic growth and improved commission and fees.
Is eHealth (EHTH) Outperforming Other Finance Stocks This Year?
by Zacks Equity Research
Is (EHTH) Outperforming Other Finance Stocks This Year?